I was actually in a Debio-025 3 yrs ago. It was just Debio and SOC though and I was unfortunately, kicked out at week 5, because of my week 4 blood draw. Since I didn't have enough of a viral load drop. Don't be nervous about it. Just ask alot of questions. Also, please don't base your decision on my experience with the Debio trial as, I have treated too many times to count and thus far, NOTHING has given me viral clearance yet. I'm currently in a trial for CTS-1027 + SOC and I'm trying my best to think positive, stay healthy as I can and PRAY! Susan400
I am surprised to not find any chatter on this forum about this drug or it's trials - There is so much talk about treatment, but none I can find on here, other than the couple of questions I have asked. makes me a bit nervous
I've been in a few clinical trials. Here's the primary questions I ask. Are rescue drugs allowed? When will the trial be unblinded (if it's a blinded trial). What are the potential side effects of said study drug? Will SOC be on each arm (since I was burned by one trial where I ended up in the no Riba arm)? If it's a placebo trial..(will they automatically roll you over onto the real drug)? Do you need to have viral clearance by week 4? Or is it just a 2 log drop? Are there any drugs on the trial (such as OTC meds, pain meds, sleep meds, antacids, vitamins, etc.) that are not allowed to be taken with the study drug and/or the Hep C meds? Those are just some of my questions I ask, right off the top of my head, that I can think of. Susan400
http://www.hivandhepatitis.com/2011_conference/easl2011/docs/0408_2010_a.html
Hi there below is the results from their 2 b trial...it shows approx 76% SVR which is a good result. however as lapis has mentioned .there are a number of things to think about when considering entering a trial I have put a link below of a thread that one of our members put up a couple of months ago..in regards to question that should be asked with regards to entering a trial ...hopfully the responses are helpful
Good luck
Will
order=107http://www.hivandhepatitis.com/2011_conference/easl2011/docs/0408_2010_a.ht
ml
http://www.medhelp.org/posts/Hepatitis-C/Things-to-ask-before-participating-in-a-trial/show/1497138?personal_page_id=1008846#post_6838455
The study is listed at clinicaltrials.gov under the name Alisporivir. Here is the link
http://clinicaltrials.gov/ct2/show/NCT01318694?term=alisporivir&rank=1
I appreciate the questions and will add them to my list - Thank you!
I had to look up this drug to give any kind of response. Here is a link to the EASL presentation of the results of the phase 2 trial.
http://www.natap.org/2011/EASL/EASL_08.htm
I went to clinicaltrials.gov and only found two debio trials but one is completed and one is ongoing but not recruiting. Both were phase 2 trials. I wonder why a phase 3 trial is not listed here, seems like it would be.
The drug looks interesting. It acts by its affect on the host protein of the liver cells, rather than being a direct-acting antiviral, like the PI drugs are. So here are some questions you might ask:
What is the tx for each of the 5 arms? What is your chance of getting SOC only vs getting the study drug? Does the study drug have additional side affects? If you become anemic or neutropenic, are rescue drugs allowed? Will your tx be response-guided or randomly assigned?
This is just a beginning, but I'm bumping you up to the top in hopes that someone else will chime in. GTG now. Best wishes to you going forward.
Lapis